JACOBS LEVY EQUITY MANAGEMENT, INC - RECRO PHARMA INC ownership

RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 82 filers reported holding RECRO PHARMA INC in Q2 2019. The put-call ratio across all filers is 0.48 and the average weighting 0.2%.

Quarter-by-quarter ownership
JACOBS LEVY EQUITY MANAGEMENT, INC ownership history of RECRO PHARMA INC
ValueSharesWeighting
Q3 2021$1,409,000
-9.9%
684,104
+1.1%
0.01%
-18.2%
Q2 2021$1,563,000
+28.4%
676,630
+55.1%
0.01%
+22.2%
Q1 2021$1,217,000
-5.4%
436,285
-3.3%
0.01%
-18.2%
Q4 2020$1,286,000
+97.2%
451,301
+45.3%
0.01%
+57.1%
Q3 2020$652,000
-55.1%
310,630
-2.7%
0.01%
-56.2%
Q2 2020$1,452,000
+82.6%
319,159
+227.9%
0.02%
+60.0%
Q1 2020$795,000
-47.6%
97,339
+17.6%
0.01%
-33.3%
Q4 2019$1,517,000
+133.0%
82,786
+40.8%
0.02%
+87.5%
Q3 2019$651,000
+149.4%
58,786
+129.1%
0.01%
+100.0%
Q2 2019$261,000
-23.0%
25,662
-55.7%
0.00%
-20.0%
Q1 2019$339,000
+6.9%
57,864
+29.6%
0.01%
-16.7%
Q4 2018$317,000
+22.4%
44,664
+22.5%
0.01%
+50.0%
Q3 2018$259,000
+39.2%
36,464
-1.6%
0.00%
+33.3%
Q2 2018$186,000
-58.0%
37,064
-7.9%
0.00%
-57.1%
Q1 2018$443,000
+51.7%
40,264
+27.6%
0.01%
+40.0%
Q4 2017$292,000
-2.0%
31,564
-4.8%
0.01%
-16.7%
Q3 2017$298,000
+38.6%
33,164
+8.5%
0.01%
+20.0%
Q2 2017$215,00030,5640.01%
Other shareholders
RECRO PHARMA INC shareholders Q2 2019
NameSharesValueWeighting ↓
Samjo Capital LLC 8,039,100$3,770,3381.48%
First Light Asset Management, LLC 19,676,396$9,228,2300.88%
AWM Investment Company, Inc. 10,266,144$4,814,8220.71%
Caligan Partners LP 1,689,768$794,1910.36%
HighMark Wealth Management LLC 484,985$227,4580.19%
Nantahala Capital Management 1,250,000$586,2500.05%
Clear Harbor Asset Management, LLC 938,847$440,3190.05%
DRIEHAUS CAPITAL MANAGEMENT LLC 4,249,229$1,992,8880.03%
TITLEIST ASSET MANAGEMENT, LLC 210,148$98,5590.02%
ROYCE & ASSOCIATES LP 3,285,082$1,540,7030.02%
View complete list of RECRO PHARMA INC shareholders